Edwards Lifesciences, a pioneering force in patient-focused medical innovations, has successfully raised an impressive $25 million to further propel its mission in the realm of cardiovascular healthcare. As the global leader in developing solutions for structural heart disease, critical care, and surgical monitoring, Edwards Lifesciences is committed to innovating life-saving technologies that enhance patient outcomes. Founded in 1958 by visionary engineer Miles Lowell Edwards, the company has a rich history rooted in the desire to mechanize the heart and improve the lives of those battling heart disease. The funding will be strategically allocated to bolster research and development initiatives, enabling the next generation of advanced medical devices and therapies. Specifically, Edwards Lifesciences aims to accelerate the design of tissue replacement heart valves and hemodynamic monitoring systems, a testament to its unwavering dedication to meet the complex needs of healthcare providers and patients alike across over 100 countries. This financing highlights the company's ethos of collaboration and innovation, as it seeks to create a robust pipeline of groundbreaking solutions. With a diverse workforce comprising clinical affairs, quality engineering, regulatory affairs, and marketing experts, Edwards Lifesciences fosters an environment where ideas can flourish. The raised capital not only signifies a critical step toward enhancing technology but also underscores the company鈥檚 commitment to a future where individuals can lead longer and healthier lives. As they continue to push boundaries in medical technology, Edwards Lifesciences remains steadfast in its goal of transforming patient care, exemplifying its founding credo that emphasizes integrity, innovation, and patient-centered focus. For more information on their legal terms and trademarks, please visit: https://www.edwards.com/legal/legal-terms.
Edwards Lifesciences Announces $25 Million in Funding to Advance Medical Innovation
Recently funded 路 $25.0MMedical Innovations
Get the full Edwards Lifesciences company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
